1.A systematic review of the mechanisms and influence factors of cancer related fatigue
Yanbo JI ; Cuiping XU ; Feifei SUN ; Guangchao GAO ; Xiaoxia YU ; Chunlu BO ; Wei SU ; Kaiwen DING
Chinese Journal of Practical Nursing 2016;32(16):1276-1280
Fatigue, which is one of the most commonly reported symptoms in cancer, can negatively impact the functional status and the health-related quality of life of individuals. Although awareness and
study of CRF have grown in recent years,the biological mechanisms and risk factors that induce CRF remain unclear.This paper systematically reviews the available evidence on the biological mechanisms and the risk factors to guide the development of targeted, individualized interventions for cancer-related fatigue.
2.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
3.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
4.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
5.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
6.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
7.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
8.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
9.The Experience and Implications of the Artificial Intelligence Payment in the US.
Chunlu YU ; Wen CHEN ; Luying ZHANG
Chinese Health Economics 2024;43(7):93-96
Objective:To summarize the main practices and experiences of the Centers for Medicare&Medicaid Services in the US.to pay for artificial intelligence(AI),which can provide references for the formulation of health insurance payment policies in China.Methods:Based on the literature study,it systematically analyzed the payment mechanism and typical cases of AI pay-ment in the US.Results:The US.has established four payment mechanisms for AI used in inpatient,outpatient and physician ser-vices,and set clear criteria for inclusion and payment,which has facilitated the clinical use of AI.Conclusion:It is suggested that China establish the payment mechanism for AI,focus on the clinical benefits of AI,and be alert of the overuse of AI.
10.Clinical value of peroral endoscopic cardial constriction for gastroesophageal reflux disease
Haiqing HU ; Haijing ZHANG ; Chunlu JIN ; Xuemei YU
Chinese Journal of Digestive Endoscopy 2019;36(8):563-567
Objective To study the safety and efficacy of peroral endoscopic cardial constriction (PECC) for gastroesophageal reflux disease (GERD). Methods A total of 27 patients with GERD who visited the Affiliated Hospital of Inner Mongolia Medical University from August 2016 to December 2017 and met the inclusion criteria received PECC. The 24 h esophageal pH-resistance monitoring ( DeMeester ) scores, GERD health-related quality of life ( GERD-HRQL ) scores, GERD-questionnaires ( GERD-Q ) symptom scores and clinical efficacy before and after operation were compared. Results DeMeester score at 3 months ( Z=-6. 940, P=0. 001) and 6 months ( Z=-6. 307, P=0. 001) after treatment, GERD-HRQL score at 3 months ( t=11. 499, P=0. 001) and 6 months ( t=10. 959, P=0. 001) as well as GERD-Q symptom score at 3 months ( t=30. 647, P=0. 001) and 6 months ( t=27. 217, P =0. 001) after surgery significantly decreased, compared with those before. The curative rates were 81. 5％ ( 22/27) and 77. 8％(21/27) at 3 months and 6 months after operation. Conclusion PECC, a new method for the treatment of GERD with good short-term effect, safety and feasibility,can be recommended for clinical application.
Result Analysis
Print
Save
E-mail